|
FY2026
12 months to Jul 31, 2026
|
FY2025
12 months to Jul 31, 2025
|
FY2024
12 months to Jul 31, 2024
|
FY2023
12 months to Jul 31, 2023
|
FY2022
12 months to Jul 31, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative | |||||
| Loss on impairment of intangible assets | |||||
| Gain on sale of fixed assets | |||||
| Research and development | |||||
| Operating expenses | |||||
| Operating income | |||||
| Interest expense | |||||
| Other income, net | |||||
| Earnings before income taxes | |||||
| Income taxes | |||||
| Net earnings | |||||
| Weighted average shares – basic (in shares) | |||||
| Weighted average shares – diluted (in shares) | |||||
| Net earnings per share – basic (in usd per share) | |||||
| Net earnings per share – diluted (in usd per share) |
Loading...
